Mariner’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Mariner’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$291K	Sell	1,173 -152	-11%	-$32.7K	﹤0.01%	2869
2026 Q1	$266K	Sell	1,325 -185	-12%	-$38.3K	﹤0.01%	2976
2025 Q4	$312K	Buy	1,510 +113	+8%	+$22.6K	﹤0.01%	2806
2025 Q3	$250K	Sell	1,397 -1,328	-49%	-$226K	﹤0.01%	2971
2025 Q2	$440K	Buy	2,725 +1,467	+117%	+$234K	﹤0.01%	2437
2025 Q1	$214K	Buy	+1,258	New	+$218K	﹤0.01%	2941
2024 Q1	–	Sell	-1,712	Closed	-$271K	–	3164
2023 Q4	$271K	Buy	+1,712	New	+$246K	﹤0.01%	2438
2023 Q3	–	Sell	-1,316	Closed	-$202K	–	2940
2023 Q2	$202K	Sell	1,316 -27	-2%	-$4.21K	﹤0.01%	2459
2023 Q1	$208K	Sell	1,343 -59	-4%	-$9.27K	﹤0.01%	2388
2022 Q4	$216K	Buy	+1,402	New	+$207K	﹤0.01%	2291
2022 Q1	–	Sell	-14,280	Closed	-$2.31M	–	1388
2021 Q4	$2.31M	Buy	+14,280	New	+$2.31M	0.01%	625
2016 Q4	–	Sell	-110	Closed	-$11K	–	635
2016 Q3	$11K	Buy	+110	New	+$10.8K	﹤0.01%	727

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Mariner's FBT Position: Q2 2026 in Review

Mariner reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 11% in Q2 2026, selling an estimated $32.7K and leaving 1,173 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #2869.

Mariner first reported a position in FBT in Q3 2016 and has held it in 12 quarters since. The position peaked at $2.31M in Q4 2021. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Mariner held 1,173 shares of First Trust NYSE Arca Biotechnology Index Fund worth $291K as of Q2 2026.
Mariner sold 152 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $32.7K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2869 holding.
Mariner first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2016 and has held it in 12 quarters since.
Mariner's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.31M in Q4 2021.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.